American Well Corporation AMWL NYSE

NYSE • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score

40/100

2/7 Pass

SharesGrow Intrinsic Value

Income Statement Balance Sheet Cash Flow Statement

Annual Quarterly

American Well Corporation (AMWL) generated $-65.95M in operating cash flow for fiscal year 2025. After capital expenditures of $21K, free cash flow was $-65.97M.

Free cash flow margin was -26.5% of revenue. Cash conversion ratio was 0.69x, suggesting some earnings are non-cash.

The company returned $4K in share buybacks to shareholders during the period.

Criteria supported by this page:

HEALTH (100/100, Pass) — demonstrate the company can comfortably service its debt
MOAT (58/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
INCOME (10/100) — Cash conversion ratio was 0.69x suggests some earnings are non-cash items

Overall SharesGrow Score: 40/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score

40/100

SG Score

View full scorecard →

✓

VALUE

73/100

Price-to-Earnings & upside

→ Valuation

✗

FUTURE

26/100

Analyst consensus

→ Forecast

✗

PAST

0/100

→ Income

✓

HEALTH

100/100

Debt-to-Equity & liquidity

Proven by this page

MOAT

58/100

Proven by this page

✗

GROWTH

15/100

→ Income

✗

INCOME

10/100

→ Income

American Well Corporation Cash Flow History

Metric	TTM	FY2025	FY2024	FY2023	FY2022
Operating Cash Flow	$-65.95M	$-65.95M	$-127.34M	$-148.34M	$-192.32M
Capital Expenditure	$-21K	$-21K	$-15.22M	$-15.25M	$-10.45M
Free Cash Flow	$-65.97M	$-65.97M	$-142.56M	$-163.59M	$-202.77M